Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study

Authors:

Abstract
No abstract available
Funding Information
  • Cancer Research UK

This publication has 21 references indexed in Scilit: